NFE2L2 and Friedreich ataxia: Dyclonine had never been described to induce Nrf2, and we demonstrated a dose-dependent stimulation, and that multiple Nrf2-target proteins are elevated after treatment with dyclonine in both FA patient cells and animal model tissues (Fig. 3B).